✦ LIBER ✦

Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

✍ Scribed by Low, Jenny G; Sung, Cynthia; Wijaya, Limin; Wei, Yuan; Rathore, Abhay P S; Watanabe, Satoru; Tan, Boon Hian; Toh, Liying; Chua, Lian Tee; Hou, Yan'an; Chow, Angelia; Howe, Shiqin; Chan, Wing Ki; Tan, Kah Hin; Chung, Jasmine S; Cherng, Benjamin P; Lye, David C; Tambayah, Paul A; Ng, Lee Ching; Connolly, John; Hibberd, Martin L; Leo, Yee Sin; Cheung, Yin Bun; Ooi, Eng Eong; Vasudevan, Subhash G

Book ID: 124116606
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 320 KB
Volume: 14
Category: Article
ISSN: 1473-3099
DOI: 10.1016/S1473-3099(14)70730-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Fasudil in Patien

Efficacy and Safety of Fasudil in Patients With Stable Angina: A Double-Blind, Placebo-Controlled, Phase 2 Trial

✍ Ralph M. Vicari; Bernard Chaitman; Deborah Keefe; William B. Smith; Steven G. Ch 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Efficacy and safety of tocilizumab in pa

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

✍ Shumpei Yokota; Tomoyuki Imagawa; Masaaki Mori; Takako Miyamae; Yukoh Aihara; Sh 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 225 KB

Safety and efficacy of fingolimod in pat

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

✍ Calabresi, Peter A; Radue, Ernst-Wilhelm; Goodin, Douglas; Jeffery, Douglas; Ram 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 290 KB

Safety and efficacy of NA-1 in patients

Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial

✍ Michael D Hill; Renee H Martin; David Mikulis; John H Wong; Frank L Silver; Kare 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 385 KB

Efficacy and safety of sorafenib in pati

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

✍ Ann-Lii Cheng; Yoon-Koo Kang; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 195 KB

Efficacy and safety of sorafenib in pati

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

✍ Ann-Lii Cheng; Yoon-Koo Kang; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 195 KB

## Background: Most cases of hepatocellular carcinoma occur in the asia-pacific region, where chronic hepatitis b infection is an important aetiological factor. assessing the efficacy and safety of new therapeutic options in an asia-pacific population is thus important. we did a multinational phase